Most interestingly, however, previous evidence suggests that at least CD16A mediates NK cell cytotoxicity in the absence of cell surface antigen-bound antibodies consistent with its ability to directly recognize poorly defined, cell surface ligand(s) expressed by tumor target cells (Mandelboim et al, 1999). The gene discussed is FCGR3A; the disease is neoplasm.